PURPOSE: We determined the relationship between total optic nerve axon counts and peripapillary retinal nerve fiber layer thickness (RNFLT) measured in vivo by spectral domain optical coherence tomography (SDOCT). METHODS: A total of 22 rhesus macaques had three or more baseline measurements in both eyes of peripapillary RNFLT made by SDOCT. Laser photocoagulation then was applied to the trabecular meshwork of one eye to induce chronic unilateral IOP elevation. SDOCT measurements of RNFLT continued approximately every two weeks until the predefined study endpoint was reached in each animal. At endpoint, animals were sacrificed and the optic nerve was sampled approximately 2 mm behind the globe to obtain thin sections for histologic processing and automated axon counting across 100% of the optic nerve cross-sectional area. RESULTS: At the final imaging session, the average loss of RNFLT was 20 ± 21%, ranging from essentially no loss to nearly 65% loss. Total optic nerve axon count in control eyes ranged from 812,478 to 1,280,474. The absolute number of optic nerve axons was related linearly to RNFLT (axon count = 12,336 × RNFLT((μm)) - 257,050, R(2) = 0.65, P < 0.0001), with a Pearson correlation coefficient of 0.81. There also was a strong linear relationship between relative optic nerve axon loss (glaucomatous-to-control eye) and relative RNFLT at the final imaging session, with a slope close to unity but a significantly negative intercept (relative axon loss((%)) = 1.05 × relative RNFLT loss((%)) - 14.4%, R(2) = 0.75, P < 0.0001). The negative intercept was robust to variations of fitted model because relative axon loss was -14% on average for all experimental glaucoma (EG) eyes within 6% (measurement noise) of zero relative loss. CONCLUSIONS: There is a strong linear relationship between total optic nerve axon count and RNFLT measured in vivo by SDOCT. However, substantial loss of optic nerve axons (∼10%-15%) exists before any loss of RNFLT manifests and this discrepancy persists systematically throughout a wide range of damage.
PURPOSE: We determined the relationship between total optic nerve axon counts and peripapillary retinal nerve fiber layer thickness (RNFLT) measured in vivo by spectral domain optical coherence tomography (SDOCT). METHODS: A total of 22 rhesus macaques had three or more baseline measurements in both eyes of peripapillary RNFLT made by SDOCT. Laser photocoagulation then was applied to the trabecular meshwork of one eye to induce chronic unilateral IOP elevation. SDOCT measurements of RNFLT continued approximately every two weeks until the predefined study endpoint was reached in each animal. At endpoint, animals were sacrificed and the optic nerve was sampled approximately 2 mm behind the globe to obtain thin sections for histologic processing and automated axon counting across 100% of the optic nerve cross-sectional area. RESULTS: At the final imaging session, the average loss of RNFLT was 20 ± 21%, ranging from essentially no loss to nearly 65% loss. Total optic nerve axon count in control eyes ranged from 812,478 to 1,280,474. The absolute number of optic nerve axons was related linearly to RNFLT (axon count = 12,336 × RNFLT((μm)) - 257,050, R(2) = 0.65, P < 0.0001), with a Pearson correlation coefficient of 0.81. There also was a strong linear relationship between relative optic nerve axon loss (glaucomatous-to-control eye) and relative RNFLT at the final imaging session, with a slope close to unity but a significantly negative intercept (relative axon loss((%)) = 1.05 × relative RNFLT loss((%)) - 14.4%, R(2) = 0.75, P < 0.0001). The negative intercept was robust to variations of fitted model because relative axon loss was -14% on average for all experimental glaucoma (EG) eyes within 6% (measurement noise) of zero relative loss. CONCLUSIONS: There is a strong linear relationship between total optic nerve axon count and RNFLT measured in vivo by SDOCT. However, substantial loss of optic nerve axons (∼10%-15%) exists before any loss of RNFLT manifests and this discrepancy persists systematically throughout a wide range of damage.
Authors: Joel S Schuman; Tamar Pedut-Kloizman; Helena Pakter; Nan Wang; Viviane Guedes; Lina Huang; Liselotte Pieroth; Wayne Scott; Michael R Hee; James G Fujimoto; Hiroshi Ishikawa; Richard A Bilonick; Larry Kagemann; Gadi Wollstein Journal: Invest Ophthalmol Vis Sci Date: 2007-08 Impact factor: 4.799
Authors: Keith R G Martin; Harry A Quigley; Danielle Valenta; Jennifer Kielczewski; Mary Ellen Pease Journal: Exp Eye Res Date: 2006-03-20 Impact factor: 3.467
Authors: Chandrakumar Balaratnasingam; William H Morgan; Louise Bass; Graeme Matich; Stephen J Cringle; Dao-Yi Yu Journal: Invest Ophthalmol Vis Sci Date: 2007-08 Impact factor: 4.799
Authors: Gareth R Howell; Richard T Libby; Tatjana C Jakobs; Richard S Smith; F Campbell Phalan; Joseph W Barter; Jessica M Barbay; Jeffrey K Marchant; Nagaraju Mahesh; Vittorio Porciatti; Alan V Whitmore; Richard H Masland; Simon W M John Journal: J Cell Biol Date: 2007-12-24 Impact factor: 10.539
Authors: Navid Amini; Sara Nowroozizadeh; Nila Cirineo; Sharon Henry; Ted Chang; Tom Chou; Anne L Coleman; Joseph Caprioli; Kouros Nouri-Mahdavi Journal: Invest Ophthalmol Vis Sci Date: 2014-10-09 Impact factor: 4.799
Authors: Lin Wang; Grant A Cull; Chelsea Piper; Claude F Burgoyne; Brad Fortune Journal: Invest Ophthalmol Vis Sci Date: 2012-12-17 Impact factor: 4.799
Authors: Neil R Miller; Mary A Johnson; Theresa Nolan; Yan Guo; Steven L Bernstein Journal: Invest Ophthalmol Vis Sci Date: 2015-12 Impact factor: 4.799
Authors: Stuart K Gardiner; Ruojin Ren; Hongli Yang; Brad Fortune; Claude F Burgoyne; Shaban Demirel Journal: Am J Ophthalmol Date: 2013-11-13 Impact factor: 5.258